Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 390,928 shares at $162.97 ($61.4M) on 2020-12-18, disclosed to the SEC on 2020-12-22.
Open-market sale of $61.4M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.23 | 21,207 | $3.3M | 5.4% |
| 2 | $155.23 | 21,207 | $3.3M | 5.4% |
| 3 | $155.24 | 21,612 | $3.4M | 5.5% |
| 4 | $155.24 | 21,612 | $3.4M | 5.5% |
| 5 | $156.08 | 24,973 | $3.9M | 6.3% |
| 6 | $156.08 | 24,973 |
| $3.9M |
| 6.3% |
| 7 | $156.09 | 24,286 | $3.8M | 6.2% |
| 8 | $156.09 | 24,286 | $3.8M | 6.2% |
| 9 | $157.01 | 23,601 | $3.7M | 6.0% |
| 10 | $157.01 | 23,601 | $3.7M | 6.0% |
| 11 | $157.04 | 24,656 | $3.9M | 6.3% |
| 12 | $157.04 | 24,656 | $3.9M | 6.3% |
| 13 | $158.06 | 10,077 | $1.6M | 2.6% |
| 14 | $158.06 | 10,077 | $1.6M | 2.6% |
| 15 | $158.09 | 9,183 | $1.5M | 2.4% |
| 16 | $158.09 | 9,183 | $1.5M | 2.4% |
| 17 | $159.27 | 4,790 | $763K | 1.2% |
| 18 | $159.27 | 4,790 | $763K | 1.2% |
| 19 | $159.32 | 4,500 | $717K | 1.2% |
| 20 | $160.25 | 12,092 | $1.9M | 3.2% |
| 21 | $160.27 | 11,686 | $1.9M | 3.0% |
| 22 | $160.27 | 11,686 | $1.9M | 3.0% |
| 23 | $160.99 | 3,500 | $563K | 0.9% |
| 24 | $161.11 | 4,014 | $647K | 1.1% |
| 25 | $161.11 | 4,014 | $647K | 1.1% |
| 26 | $162.17 | 1,426 | $231K | 0.4% |
| 27 | $162.17 | 1,426 | $231K | 0.4% |
| 28 | $162.35 | 1,700 | $276K | 0.4% |
| 29 | $162.97 | 1,300 | $212K | 0.3% |
| 30 | $163.35 | 536 | $88K | 0.1% |
| 31 | $163.35 | 536 | $88K | 0.1% |
| 32 | $164.11 | 500 | $82K | 0.1% |
| 33 | $164.96 | 971 | $160K | 0.3% |
| 34 | $164.96 | 971 | $160K | 0.3% |
| 35 | $165.38 | 700 | $116K | 0.2% |
| 36 | $166.08 | 400 | $66K | 0.1% |
| 37 | $166.17 | 200 | $33K | 0.1% |
| Total | $157.17 avg | 390,928 | $61.4M | 100% |
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |
| NVCR | SELL | 2019-11-26 | $9.8M | — | Filing → |